Statistics
Publications
70
Citations
7.6K
H-Index
41
Active since
1999
Jeremy L. Jenkins is an author at Novartis (Switzerland) specializing in drug discovery, pharmacy, and drug design.
Publications per year
1999–2024
70
70
Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
Eric S. Fischer, Kerstin Böhm, John R. Lydeard et al. · Nature · 2014 · 1.1K citations · Full text
Large-scale prediction and testing of drug activity on side-effect targets
Eugen Lounkine, Michael J. Keiser, Steven Whitebread et al. · Nature · 2012 · 897 citations · Full text
1–5 of 70